Skip to main content

Table 2 Median pharmacokinetic parameters with lower and upper confidence intervals of meloxicam in control and surgery groups following intravenous (0.2 mg/kg) administration to bitches (n = 8)

From: The effect of surgery (Ovariohysterectomy) on the plasma disposition of meloxicam following intravenous administration in dogs

Parameters

Control group

Surgery group

P values

T1/2λz (h)

17.21 (12.8–40.1)

12.77 (9.8–24.3)

0.289

C0 (μg/ml)

1.05 (0.7–9.92)

5.3 (1.9–14.2)

0.298

AUClast (μg.h/ml)

21.2 (10.8–30.8)

28.5 (18.7–45.6)

0.176

AUC0→∞ (μg.h/ml)

23.0 (12.4–41.0)

29.5 (19.4–51.5)

0.322

AUMC0→∞ (μg.h2/ml)

698 (378–2815)

588 (329–2150)

0.959

Cl B (ml.h/kg)

10.5 (6.0–20.6)

7.7 (4.9–11.35)

0.191

Vdss (ml/kg)

263.0 (211–470)

149.3 (122.4–172.7)

0.016*

MRT0→∞ (h)

28.1 (19.5–56.0)

20.7 (14.4–34.3)

0.303

  1. C0: plasma concentration at time 0, AUC0→∞: area under the (zero moment) curve from time 0 to infinity, T1/2λz: terminal half-life, AUMC0→∞: area under the moment curve from time 0 to infinity; Cl B : total body clearance of drug; Vdss: volume of distribution at steady-state; MRT0→∞: mean residence time
  2. *The kinetic parameters in control group are significantly different (P < 0.05) from the surgery group